3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
19
Esophageal Squamous Cell Carcinoma
5
Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Rectal Neoplasms
3
Head and Neck Neoplasms
3
Carcinoma, Hepatocellular
3
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Ovarian Neoplasms
2
Neoplasm, Residual
2
Neoplasm Metastasis
2
Lymphoma, Large B-Cell, Diffuse
2
Lung Neoplasms
2
Esophageal Neoplasms
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Waldenstrom Macroglobulinemia
1
Urinary Bladder Neoplasms
1
Turcot syndrome
1
Testicular Neoplasms
1
Surgery
1
Stress, Psychological
1
Squamous Cell Carcinoma of External Auditory Canal
1
Solitary Fibrous Tumor, Pleural
1
Seminoma
1
Recurrence
1
Postoperative Complications
1
Interventions
Temozolomide
18
Magnetic Resonance Spectroscopy
15
Specimen Handling
13
Radiotherapy
13
Radiation
9
Biopsy
5
pembrolizumab
4
Radiotherapy, Intensity-Modulated
4
Nivolumab
4
Bevacizumab
4
vorasidenib
3
trametinib
3
Surgical Procedures, Operative
3
Spinal Puncture
3
tovorafenib
2
dabrafenib
2
Restraint, Physical
2
Leukapheresis
2
Ipilimumab
2
Genetic Therapy
2
Fluorodeoxyglucose F18
2
Eflornithine
2
Craniotomy
2
Carboplatin
2
14-methyl-20-oxa-5,7,14,26-tetraazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8(27),9,11,16,21,23-decaene
2
vocimagene amiretrorepvec
1
veliparib
1
trastuzumab deruxtecan
1
tocilizumab
1
ribociclib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Astrocytoma
×
Neoadjuvant Therapy
×
1 year
×
Clear all
No trials found.